微光基因于2021年在苏州成立,以基因编辑工具和细胞基因治疗方法开发为核心,致力于针对罕见病、难治性疾病及衰老相关疾病的药物研发与产业化。公司团队在基因编辑、蛋白质科学及衰老、罕见病等研究领域有深厚积累,并已开发出具有底层自主知识产权、可在全球自由实施的新型基因编辑工具包。公司产品管线均使用新型基因编辑工具,产品管线在同步、快速、有效地推进临床前工作,公司核心管线具备全球稀缺性。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows